Skip to main content
Top
Published in: Journal of Neurology 1/2024

Open Access 14-12-2023 | Propranolol | Journal club

Cavernomas: to treat or not to treat?

Authors: Sophie Voase, Neil P. Robertson

Published in: Journal of Neurology | Issue 1/2024

Login to get access

Excerpt

Cerebral cavernous malformations (CCMs), also referred to as cavernomas or cavernous angiomas, can occur sporadically or as an inherited trait. CCMs can be asymptomatic and incidental findings on brain imaging or symptomatic because of haemorrhage, seizures, or headaches. Haemorrhage risk for CCMs vary according to whether they are incidentally detected and unruptured or have previously bled. The re-haemorrhage rate for CCMs is between 4.5 and 22.9% annually if there has been a single haemorrhage event, or up to 33% if there have been multiple previous events. Currently, there is no consensus on acute or longer term management of CCMs. In this month’s journal club, we explore three recent studies investigating interventions to reduce future haemorrhage risk and that propose future management strategies for symptomatic CCMs. …
Metadata
Title
Cavernomas: to treat or not to treat?
Authors
Sophie Voase
Neil P. Robertson
Publication date
14-12-2023
Publisher
Springer Berlin Heidelberg
Keyword
Propranolol
Published in
Journal of Neurology / Issue 1/2024
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-023-12115-0

Other articles of this Issue 1/2024

Journal of Neurology 1/2024 Go to the issue